Standard-dose epirubicin increases the pathological complete response rate in neoadjuvant chemotherapy for breast cancer: a multicenter retrospective study

BACKGROUND: Neoadjuvant chemotherapy (NAC) has become the best comprehensive treatment choice for breast cancer. Epirubicin is a crucial drug widely used in breast cancer chemotherapy, but it is often used with a reduced dosage in NAC for Chinese patients for its notable cardiotoxicity and frequent...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gland Surg
Autors principals: Shan, Ben-Jie, Shen, Xia-Bo, Jin, Wei, Dong, Meng-Hao, Han, Xing-Hua, Lin, Lin, Chen, Jian, Huang, Da-Bing, Qian, Jun, Zhang, Jing-Jie, Pan, Yue-Yin
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475373/
https://ncbi.nlm.nih.gov/pubmed/32953611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-647
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars